ROSSARI BIOTECH Financial Statement Analysis
|
||
The Revenues of ROSSARI BIOTECH have increased by 109.06% YoY .
The Earnings Per Share (EPS) of ROSSARI BIOTECH has increased by 9.64 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
ROSSARI BIOTECH Last 5 Annual Financial Results
[BOM: 543213|NSE : ROSSARI]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹1,483 Cr | ₹709 Cr | ₹600 Cr | ₹516 Cr | ₹291,798,727 Cr |
Expenses | ₹1,307 Cr | ₹586 Cr | ₹495 Cr | ₹439 Cr | ₹247,141,846 Cr |
Operating Profit (Excl OI) | ₹176 Cr | ₹123 Cr | ₹105 Cr | ₹78 Cr | ₹44,656,881 Cr |
Other Income | ₹19 Cr | ₹9.19 Cr | ₹3.72 Cr | ₹0.91 Cr | ₹1,407,285 Cr |
Interest | ₹13 Cr | ₹2.99 Cr | ₹3.56 Cr | ₹2.88 Cr | ₹1,356,536 Cr |
Depreciation | ₹48 Cr | ₹23 Cr | ₹17 Cr | ₹12 Cr | ₹5,160,846 Cr |
Profit Before Tax | ₹136 Cr | ₹107 Cr | ₹88 Cr | ₹63 Cr | ₹39,546,784 Cr |
Profit After Tax | ₹98 Cr | ₹80 Cr | ₹65 Cr | ₹46 Cr | ₹29,013,037 Cr |
Consolidated Net Profit | ₹98 Cr | ₹80 Cr | ₹65 Cr | ₹46 Cr | ₹29,013,037 Cr |
Earnings Per Share (Rs) | ₹19.45 | ₹17.74 | ₹15.45 | ₹12.86 | ₹103.83 |
PAT Margin (%) | 6.43 | 6.56 | 11.19 | 10.82 | 8.84 |
ROE(%) | 12.52 | 16.17 | 23.11 | 31.83 | 41.88 |
ROCE(%) | 18.48 | 24.37 | 28.81 | 37.93 | 54.40 |
Total Debt/Equity(x) | 0.08 | 0.01 | 0.00 | 0.23 | 0.04 |
Key Financials |
||
Market Cap | : | ₹ 4,009.5 Cr |
Revenue (TTM) | : | ₹ 1,830.6 Cr |
Net Profit(TTM) | : | ₹ 130.5 Cr |
EPS (TTM) | : | ₹ 23.6 |
P/E (TTM) | : | 30.7 |
Industry Peers & Returns | 1W | 1M | 1Y |
ROSSARI BIOTECH | -5.7% | 3.8% | 6.5% |
PIDILITE INDUSTRIES | -1.1% | -3.3% | 23.6% |
SOLAR INDUSTRIES INDIA | 2.5% | 3.2% | 132% |
SRF | -2.7% | -2% | 5% |
GUJARAT FLUOROCHEMICALS | -1.9% | 11.9% | 7.4% |
DEEPAK NITRITE | -1.4% | 14.2% | 31.3% |
TATA CHEMICALS | -2.8% | 0.4% | 15.5% |
GODREJ INDUSTRIES | NA | 10.1% | 98.3% |
AARTI INDUSTRIES | -1.4% | 7.7% | 32.2% |
ROSSARI BIOTECH Revenues
[BOM: 543213|NSE : ROSSARI]
Y-o-Y | 109.06 % |
5 Yr CAGR | -95.25 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹1,483 Cr | 109.06 | |
Mar2022 | ₹709 Cr | 18.21 | |
Mar2021 | ₹600 Cr | 16.25 | |
Mar2020 | ₹516 Cr | -100.00 | |
Mar2019 | ₹291,798,727 Cr | - |
ROSSARI BIOTECH Operating Profit
[BOM: 543213|NSE : ROSSARI]
Y-o-Y | 43.26 % |
5 Yr CAGR | -95.54 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹176 Cr | 43.26 | |
Mar2022 | ₹123 Cr | 17.48 | |
Mar2021 | ₹105 Cr | 35.06 | |
Mar2020 | ₹78 Cr | -100.00 | |
Mar2019 | ₹44,656,881 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -31.47 % |
5 Yr CAGR | -6.11 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 11.89% | -31.47 | |
Mar2022 | 17.35% | -0.57 | |
Mar2021 | 17.45% | 16.18 | |
Mar2020 | 15.02% | -1.83 | |
Mar2019 | 15.3% | - |
ROSSARI BIOTECH Profit After Tax
[BOM: 543213|NSE : ROSSARI]
Y-o-Y | 21.76 % |
5 Yr CAGR | -95.72 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹98 Cr | 21.76 | |
Mar2022 | ₹80 Cr | 22.94 | |
Mar2021 | ₹65 Cr | 42.84 | |
Mar2020 | ₹46 Cr | -100.00 | |
Mar2019 | ₹29,013,037 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -1.98 % |
5 Yr CAGR | -7.65 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 6.43 % | -1.98 | |
Mar2022 | 6.56 % | -41.38 | |
Mar2021 | 11.19 % | 3.42 | |
Mar2020 | 10.82 % | 22.40 | |
Mar2019 | 8.84 % | - |
ROSSARI BIOTECH Earnings Per Share (EPS)
[BOM: 543213|NSE : ROSSARI]
Y-o-Y | 9.64 % |
5 Yr CAGR | -34.21 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹19 | 9.64 | |
Mar2022 | ₹18 | 14.82 | |
Mar2021 | ₹15 | 20.14 | |
Mar2020 | ₹13 | -87.61 | |
Mar2019 | ₹104 | - |
ROSSARI BIOTECH Return on Capital Employed (ROCE)
[BOM: 543213|NSE : ROSSARI]
Y-o-Y | -24.17 % |
5 Yr CAGR | -23.66 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 18.48% | -24.17 | |
Mar2022 | 24.37% | -15.41 | |
Mar2021 | 28.81% | -24.04 | |
Mar2020 | 37.93% | -30.28 | |
Mar2019 | 54.4% | - |
ROSSARI BIOTECH Share Price vs Sensex
Current Share Price | : | ₹726.4 |
Current MarketCap | : | ₹ 4,009.5 Cr |
Updated EOD on | : | May 03,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ROSSARI BIOTECH | -5.7% |
3.8% |
6.5% |
SENSEX | -0.6% |
0.3% |
21.8% |
ROSSARI BIOTECH related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 400 MIDSMALLCAP | 1.7% | 8% | 61.5% |
S&P BSE MIDSMALLCAP | 1.4% | 8.6% | 66.5% |
S&P BSE 500 | 0.5% | 3.2% | 37.9% |
S&P BSE ALLCAP | 0.4% | 3.7% | 40% |
S&P BSE 250 SMALLCAP | 0.2% | 9.5% | 63.1% |
You may also like the below Video Courses
FAQ about ROSSARI BIOTECH Financials
How the annual revenues of ROSSARI BIOTECH have changed ?
The Revenues of ROSSARI BIOTECH have increased by 109.06% YoY .
How the Earnings per Share (EPS) of ROSSARI BIOTECH have changed?
The Earnings Per Share (EPS) of ROSSARI BIOTECH has increased by 9.64 % YoY .
PIDILITE INDUSTRIES LTD vs SOLAR INDUSTRIES INDIA LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs DEEPAK NITRITE LTD vs